Page last updated: 2024-11-06

mitomycin and Hemorrhagic Shock

mitomycin has been researched along with Hemorrhagic Shock in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"Three cases of ruptured hepatocellular carcinomas were treated: one case by emergency hepatectomy, and two cases by hepatectomy following TAE."1.28[Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma]. ( Itoh, H; Kaiho, T; Kanno, Y; Kimura, F; Koshikawa, H; Matsumoto, J; Miyazaki, M; Nakajima, T; Teramoto, O; Udagawa, I, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, M1
Udagawa, I1
Koshikawa, H1
Itoh, H1
Kanno, Y1
Teramoto, O1
Nakajima, T1
Kaiho, T1
Kimura, F1
Matsumoto, J1

Other Studies

1 other study available for mitomycin and Hemorrhagic Shock

ArticleYear
[Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma].
    Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:7

    Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Isc

1989